Federal contract award
75A50124C00011
VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $811.9K |
| Current contract value | $811.9K |
| Potential contract value / ceiling | $811.9K |
| Start date | Mar 12, 2024 |
| Current end date | Dec 16, 2024 |
| Potential end date | Dec 16, 2024 |
| Latest award activity | Jun 5, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 5, 2025 | P00002 | $-42.1K | DE-OBLIGATE FUNDING FOR CONTRACT CLOSEOUT. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.